MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study.
Eugene HanHo Soo ChunYong-Ho LeeJae Seung LeeHye-Won LeeBeom Kyung KimJun Yong ParkDo Young KimByung-Wan LeeEun Seok KangBong-Soo ChaSang Hoon AhnSeung-Up KimPublished in: Journal of gastroenterology and hepatology (2023)
The risks of sarcopenia and CVD were significantly higher in MAFLD group but did not differ according to fibrotic burden in non-MR NAFLD group. The MAFLD criteria might be better for identifying high-risk fatty liver disease than the NAFLD criteria.